| Metric | Q1'25 | Q2'25 | Change |
|---|---|---|---|
| Production (Bcfe) | Q1: 560-580 (flat YoY) | Q2: 575-595 at high end (up 2% YoY) | +25 Bcfe midpoint raise for full year |
| Free Cash Flow | Q1: $1.0B (record quarter) | Q2: $240M reported, $375M adjusted | Down 76% sequentially on legal settlement |
| Net Debt | Q1: $8.1B | Q2: $7.8B | $350M reduction, on track for $7.5B target |
| Capital Spending | Q1: Below guidance | Q2: $50M below low end of guidance | Accelerating efficiency gains |
| Operating Expense (per Mcfe) | Q1: Not specified | Q2: Lowered by $0.06 | 6 cents improvement from Olympus synergies |
| Compression Program Status | Q1: Ongoing | Q2: Ahead of schedule, below budget | Delivering 2x expected production uplift |
| Strategic Growth CapEx Pipeline | Q1: Conceptual | Q2: $1B identified projects | Concrete opportunities crystallized |
| In-Basin Demand Commitments | Q1: 'Discussions with dozen projects' | Q2: 1.5+ Bcf/d signed | From talks to signed deals |
| Hedging Position 2026+ | Q1: Unhedged | Q2: Added 10% winter collars $4-7 | Tactical hedging resumed |
| Equitrans Synergies Captured | Q1: 70% of target | Q2: 85% of target ($360M annual) | +$85M incremental synergies found |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.